Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
iPSC Models for Cystic Fibrosis Drug Testing
2026-09-02
The reference study develops a multimodal induced pluripotent stem cell platform that converts patient-specific CFTR genotypes into airway epithelial models for drug testing. By combining forskolin-induced swelling in three-dimensional spheroids with functional testing of polarized mucociliary cultures, the work reveals genotype-dependent baseline activity and responses to CFTR modulators, including in rare-variant disease models.
-
Gefitinib (ZD1839) EGFR Research Workflows
2026-09-01
Build reproducible EGFR signaling experiments with Gefitinib (ZD1839), from phosphoprotein assays and tumor models to emerging blue-light skin-barrier workflows. The guide separates established product benchmarks from practical optimization recommendations so researchers can test pathway causality without overinterpreting cytotoxicity.
-
GnRH Antagonists: Position-3 Modification and Activity
2026-09-01
Samant and colleagues examined how replacing the position-3 residue of degarelix with 3-(2-methoxy-5-pyridyl)-alanine affects GnRH receptor antagonism and duration of action. The separated stereoisomers revealed a strong stereochemical effect on in vitro potency, but neither modification preserved the parent peptide’s long-acting in vivo profile.
-
Sorafenib Workflow for Liver Cancer Research
2026-08-31
Build reproducible liver-cancer experiments with Sorafenib (BAY-43-9006), from dose-response profiling to kinase and angiogenesis readouts. A parallel workflow informed by new mitochondrial cholesterol and mitophagy findings helps distinguish direct signaling effects from broader stress responses.
-
Hydroxytyrosol for Oxidative Stress in CKD
2026-08-31
A translational framework for using Hydroxytyrosol to investigate nicotine-associated oxidative stress, inflammation, and fibrosis across renal and cardiovascular research models, with practical guidance for assay design, controls, product handling, and evidence interpretation.
-
NAD+/NADH Homeostasis in Fungal Hypoxia
2026-08-30
This award review explains how NAD+/NADH homeostasis coordinates hypoxia adaptation, energy conservation, and secondary metabolite production in filamentous fungi. Its central contribution is to connect altered redox balance with fermentation, dehydrogenase activity, and a Nudix hydrolase A–sirtuin A regulatory pathway, providing a framework for designing fungal metabolism studies.
-
(S)-(+)-Methoprene Workflows for JH Research
2026-08-29
Use (S)-(+)-Methoprene to separate juvenile hormone receptor signaling from upstream hormone biosynthesis in insect development and reproduction studies. This practical guide combines stage-aware dosing, miRNA–mRNA analysis, Met activation assays, and troubleshooting for more interpretable endocrine experiments.
-
LBP, AMPK and Mitophagy in Muscle Atrophy
2026-08-28
A 2025 study shows that Lycium barbarum polysaccharide protects skeletal muscle from high-fat-diet-associated atrophy by engaging AMPK/PINK1/Parkin-mediated mitophagy. Its combination of metabolic, mitochondrial, pharmacological, and Parkin-knockdown evidence supports a mechanistic model linking improved glucose-lipid handling with mitochondrial quality control in sarcopenic obesity.
-
UK-5099 (PF-1005023): Mechanism & Uses
2026-08-28
UK-5099, also called PF-1005023, is a mitochondrial pyruvate carrier inhibitor that blocks pyruvate entry into mitochondria. Its reported activity supports mitochondrial metabolism research, while cellular and mouse findings connect MPC inhibition with altered energy metabolism and glucose tolerance.
-
Difloxacin HCl: A Mechanism-First Research Guide
2026-08-27
Difloxacin HCl is a quinolone antimicrobial antibiotic suited to bacterial DNA replication inhibition, antimicrobial susceptibility testing, and multidrug resistance reversal research. This guide connects compound handling and assay design with a mechanistic lesson from Plk1–p31comet checkpoint biology: reliable conclusions depend on matching molecular action to the correct experimental readout.
-
QX77: A Decision Framework for Autophagy Assays
2026-08-27
QX77 is a molecular chaperone activator for dissecting LAMP2A, Rab11, and autophagy responses without conflating chaperone-mediated autophagy with mitophagy. This article translates recent ETS1–SENP2–HSPA8–FUNDC1 findings into a rigorous assay-design and interpretation framework.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-08-26
Masitinib (AB1010), SKU A2942, is a DMSO-compatible phenylaminothiazole kinase inhibitor for studying KIT, PDGFRα, PDGFRβ, selected KIT mutants, and mast-cell responses. It is appropriate for controlled biochemical and cellular research, but not for aqueous or ethanol-based workflows, broad-spectrum kinase screens, or clinical dosing decisions without separate validation.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-08-26
Song and colleagues show that murine norovirus uses the membrane-rupture factor NINJ1 to release the viral protein NS1 while simultaneously permitting broad damage-associated molecular pattern release. The study combines CRISPR screening, infection models, localization and interaction analyses, viral mutagenesis, and mouse experiments to define an unconventional secretion mechanism with physiological relevance.
-
ARCA EGFP mRNA: Workflow and Troubleshooting
2026-08-25
ARCA EGFP mRNA provides a direct fluorescence readout for comparing mammalian cell delivery, translation, and lipid nanoparticle performance. This practical guide covers assay design, quantitative controls, protocol parameters, and troubleshooting from routine transfection screens to translational mRNA delivery studies.
-
Cisplatin and Cancer Stemness: Assay Design Insights
2026-08-25
Cisplatin and CDDP remain powerful tools for studying DNA damage, apoptosis, and chemotherapy resistance. This guide connects cisplatin response testing with oral cancer stemness biology to improve assay interpretation and combination-study design.